Pacific Drilling Regains Compliance with NYSE Continued Listing Requirements
Pacific Drilling S.A. (NYSE: PACD) announced today that it has been notified by the New York Stock Exchange (“NYSE”) that it is once again in compliance with the NYSE’s continued listing requirements.
The Company previously announced that it received a notice from the NYSE on January 13, 2016 that the Company did not satisfy the $1.00 minimum share price standard for continued listing of the Company’s common shares, and the Company had until July 13, 2016 to cure the non-compliance.
At the close of trading on May 31, 2016, the Company’s common shares had a closing price per share and a 30-trading-day average closing price per share above $1.00 and accordingly, the Company has regained compliance with the continued listing standard.
About Pacific Drilling
With its best-in-class drillships and highly experienced team, Pacific Drilling is committed to becoming the industry’s preferred ultra-deepwater drilling contractor. Pacific Drilling’s fleet of seven drillships represents one of the youngest and most technologically advanced fleets in the world. For more information about Pacific Drilling, including its current Fleet Status, please visit www.pacificdrilling.com .
John Boots, +352 26 84 57 81
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
NV-RIMINI-STREET24.4.2018 18:02 | pressemeddelelse
Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation for Innovation
NOVALIQ-GMBH24.4.2018 17:55 | pressemeddelelse
Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI
PA-PPG24.4.2018 15:09 | pressemeddelelse
PPG Reports Sustainability Progress, New 2025 Goals
BIOIBERICA24.4.2018 14:19 | pressemeddelelse
Bioiberica Approves Its Combined Drug for Osteoarthritis in Five More European Countries
TX-ASURAGEN24.4.2018 14:03 | pressemeddelelse
Asuragen to Present at World CB & CDx Europe Summit in London, UK
NY-MOODY'S24.4.2018 14:02 | pressemeddelelse
Moody’s Seeks to Open Doors to a Better Future
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum